166 related articles for article (PubMed ID: 7920888)
1. Thiazolidinediones (AD-4833 and CS-045) improve hepatic insulin resistance in streptozotocin-induced diabetic rats.
Tominaga M; Igarashi M; Daimon M; Eguchi H; Matsumoto M; Sekikawa A; Yamatani K; Sasaki H
Endocr J; 1993 Jun; 40(3):343-9. PubMed ID: 7920888
[TBL] [Abstract][Full Text] [Related]
2. Effects of troglitazone on hepatic and peripheral insulin resistance induced by growth hormone excess in rats.
Sugimoto M; Takeda N; Nakashima K; Okumura S; Takami K; Yoshino K; Hattori J; Ishimori M; Takami R; Sasaki A; Yasuda K
Metabolism; 1998 Jul; 47(7):783-7. PubMed ID: 9667221
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of troglitazone and D-chiroinositol on glucosamine-induced insulin resistance in vivo in rats.
Yoshino K; Takeda N; Sugimoto M; Nakashima K; Okumura S; Hattori J; Sasaki A; Kawachi S; Takami K; Takami R; Yasuda K
Metabolism; 1999 Nov; 48(11):1418-23. PubMed ID: 10582551
[TBL] [Abstract][Full Text] [Related]
4. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats.
Fujiwara T; Yoshioka S; Yoshioka T; Ushiyama I; Horikoshi H
Diabetes; 1988 Nov; 37(11):1549-58. PubMed ID: 3053303
[TBL] [Abstract][Full Text] [Related]
5. Metabolic effects of troglitazone in the Goto-Kakizaki rat, a non-obese and normolipidemic rodent model of non-insulin-dependent diabetes mellitus.
O'Rourke CM; Davis JA; Saltiel AR; Cornicelli JA
Metabolism; 1997 Feb; 46(2):192-8. PubMed ID: 9030828
[TBL] [Abstract][Full Text] [Related]
6. Thiazolidinediones exert different effects on insulin resistance between dexamethasone-treated rats and wistar fatty rats.
Kimura M; Daimon M; Tominaga M; Manaka H; Sasaki H; Kato T
Endocr J; 2000 Feb; 47(1):21-8. PubMed ID: 10811289
[TBL] [Abstract][Full Text] [Related]
7. Effect of troglitazone on exocrine pancreas in rats with streptozotocin-induced diabetes mellitus.
Shimizu K; Shiratori K; Hayashi N; Fujiwara T; Horikoshi H
Pancreas; 2000 Nov; 21(4):421-6. PubMed ID: 11075998
[TBL] [Abstract][Full Text] [Related]
8. Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance.
Miles PD; Higo K; Romeo OM; Lee MK; Rafaat K; Olefsky JM
Diabetes; 1998 Mar; 47(3):395-400. PubMed ID: 9519745
[TBL] [Abstract][Full Text] [Related]
9. Effects of troglitazone on dexamethasone-induced insulin resistance in rats.
Okumura S; Takeda N; Takami K; Yoshino K; Hattori J; Nakashima K; Sugimoto M; Ishimori M; Takami R; Yasuda K
Metabolism; 1998 Mar; 47(3):351-4. PubMed ID: 9500576
[TBL] [Abstract][Full Text] [Related]
10. Troglitazone (CS-045) ameliorates albuminuria in streptozotocin-induced diabetic rats.
Fujii M; Takemura R; Yamaguchi M; Hasegawa G; Shigeta H; Nakano K; Kondo M
Metabolism; 1997 Sep; 46(9):981-3. PubMed ID: 9284882
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological treatments for GH-induced insulin resistance.
Sugimoto M; Takeda N; Hattori J; Yoshino K; Nakashima K; Okumura S; Ishimori M; Yasuda K
Endocr J; 1999 Mar; 46 Suppl():S51-3. PubMed ID: 12054120
[TBL] [Abstract][Full Text] [Related]
12. Metabolic effects of troglitazone on fat-induced insulin resistance in the rat.
Khoursheed M; Miles PD; Gao KM; Lee MK; Moossa AR; Olefsky JM
Metabolism; 1995 Nov; 44(11):1489-94. PubMed ID: 7476339
[TBL] [Abstract][Full Text] [Related]
13. Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat.
Lee MK; Miles PD; Khoursheed M; Gao KM; Moossa AR; Olefsky JM
Diabetes; 1994 Dec; 43(12):1435-9. PubMed ID: 7958495
[TBL] [Abstract][Full Text] [Related]
14. Troglitazone: review and assessment of its role in the treatment of patients with impaired glucose tolerance and diabetes mellitus.
Johnson MD; Campbell LK; Campbell RK
Ann Pharmacother; 1998 Mar; 32(3):337-48. PubMed ID: 9533065
[TBL] [Abstract][Full Text] [Related]
15. Effects of troglitazone and voluntary running on insulin resistance induced high fat diet in the rat.
Kitakoshi K; Oshida Y; Nakai N; Han YQ; Sato Y
Horm Metab Res; 2001 Jun; 33(6):365-9. PubMed ID: 11456287
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotective effects of troglitazone in streptozotocin-induced diabetic rats.
Shimabukuro M; Higa S; Shinzato T; Nagamine F; Komiya I; Takasu N
Metabolism; 1996 Sep; 45(9):1168-73. PubMed ID: 8781306
[TBL] [Abstract][Full Text] [Related]
17. Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects.
Frias JP; Yu JG; Kruszynska YT; Olefsky JM
Diabetes Care; 2000 Jan; 23(1):64-9. PubMed ID: 10857970
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative.
Shibata T; Matsui K; Nagao K; Shinkai H; Yonemori F; Wakitani K
Eur J Pharmacol; 1999 Jan; 364(2-3):211-9. PubMed ID: 9932726
[TBL] [Abstract][Full Text] [Related]
19. TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone.
Miles PD; Romeo OM; Higo K; Cohen A; Rafaat K; Olefsky JM
Diabetes; 1997 Nov; 46(11):1678-83. PubMed ID: 9356012
[TBL] [Abstract][Full Text] [Related]
20. Effect of troglitazone, a new oral antidiabetic agent, on fructose-induced insulin resistance.
Yagi N; Takasu N; Higa S; Ishikawa K; Murakami K; Mimura G
Horm Metab Res; 1995 Oct; 27(10):439-41. PubMed ID: 8575720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
